Company Overview of Immunotope, Inc.
Randal D. Chase Ph.D.
Chief Executive Officer of ImmunoVaccine Technologies Inc. and President of ImmunoVaccine Technologies Inc., Immunotope, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 Board Members in 6 different organizations across 10 different industries.|
See Board Relationships
Dr. Randal D. Chase, Ph.D., serves as a Business Advisor and Consultant to companies in the life science sector. Dr. Chase served as the Chief Executive Officer and President of ImmunoVaccine Inc. (alternate name, ImmunoVaccine Technologies Inc.) from 2006 to April 14, 2011 and also served as its Acting Chief Financial Officer. Dr. Chase served as the President of Global Mandate of Shire Biologics, a division of Shire Pharmaceuticals Plc from May 2001 to 2004. Dr. Chase ...
The Pennsylvania Biotechnology CenterPhone: 215-253-4180
Doylestown, Pennsylvania 18902
Board Members Memberships
Independent Non Executive Director, Member of Nominations Committee, Member of Audit Committee and Member of Remuneration Committee
Chairman and Member of Audit Committee
Chairman of the Board
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
University Of British Columbia
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Request Profile Update
Only a company representative may request an update for the company profile. Documentation will be required.
Please enter your information in the following field(s):